Food Allergy Challenge Diagnostic Study
An Exploratory Pilot Study Evaluating Various Diagnostic Measurements Taken During an Escalating Dose Oral Food Challenge to Patient Response
1 other identifier
observational
6
1 country
1
Brief Summary
The objective of this study is to correlate various diagnostic measurements taken during an escalating dose oral food challenge to the subject's response. This study will investigate whether non invasive objective biomarkers can indicate a positive response to an escalating dose OFC before a systemic reaction occurs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2015
CompletedFirst Posted
Study publicly available on registry
November 17, 2015
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedOctober 2, 2018
May 1, 2016
6 months
November 10, 2015
October 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Correlation between objective biomarker measures and challenge outcome
Correlation between imaging measurements taken before, during, and after oral food challenge to outcome of challenge
Change from baseline at 15 minute intervals until completion of challenge (approximately 3 hours)
Correlation between subjective biomarker measures and challenge outcome
Correlation between symptom questionnaire taken before, during, and after oral food challenge to outcome of challenge
Change from baseline at 15 minute intervals until completion of challenge (approximately 3 hours)
Study Arms (1)
Challenge Subjects
Male or female subjects aged 5 - 35 with suspected food allergy and an upcoming scheduled clinical food challenge
Eligibility Criteria
Subjects with suspected food allergy and scheduled upcoming oral food challenge will be recruited.
You may qualify if:
- Male or female of any race, aged 5 - 35 years with planned clinical oral food challenge;
- Have provided verbal and written informed consent. If under the age of 18, a parent/guardian must provide verbal and written informed consent;
- Be willing and able to follow instructions, including participation in study assessments, and can be present for the required study visits for the duration of the study;
You may not qualify if:
- Be unable to comply with all study parameters and procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ORA, Inc.lead
- Tufts Medical Centercollaborator
Study Sites (1)
Tufts Medical Center
Boston, Massachusetts, 02111, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Leung, M.D.
Tufts Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2015
First Posted
November 17, 2015
Study Start
March 1, 2016
Primary Completion
September 1, 2016
Study Completion
October 1, 2016
Last Updated
October 2, 2018
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share